Search hospitals
>
Georgia
>
Atlanta
Emory Saint Joseph's Hospital
Claim this profile
Atlanta, Georgia 30342
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
Conducts research for Cancer
320 reported clinical trials
58 medical researchers
Summary
Emory Saint Joseph's Hospital is a medical facility located in Atlanta, Georgia. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer, Cancer and other specialties. Emory Saint Joseph's Hospital is involved with conducting 320 clinical trials across 466 conditions. There are 58 research doctors associated with this hospital, such as Ticiana A. Leal, Conor Steuer, Olatunji Alese, and Mehmet Bilen, MD.
Area of expertise
Breast Cancer
Emory Saint Joseph's Hospital has run 63 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Emory Saint Joseph's Hospital has run 51 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Ticiana A. Leal
University of Wisconsin Hospital and Clinics
5 years of reported clinical research
Conor Steuer
Emory University Hospital Midtown
1 year of reported clinical research
Olatunji Alese
Emory University Hospital/Winship Cancer Institute
8 years of reported clinical research
Mehmet Bilen, MD
Emory University Hospital/Winship Cancer Institute
3 years of reported clinical research
Clinical Trials running at Emory Saint Joseph's Hospital
Breast Cancer
Lung Cancer
Breast cancer
Prostate Cancer
Brain Tumor
Esophageal cancer
Ovarian Cancer
Liver Cancer
Uterine Cancer
Pancreatic Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting
2 awards
Phase 3
23 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting
2 awards
Phase 3
40 criteria
Mindfulness Approaches
for Living After Breast Cancer
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.
Recruiting
2 awards
Phase 3
5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Emory Saint Joseph's Hospital?
Emory Saint Joseph's Hospital is a medical facility located in Atlanta, Georgia. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer, Cancer and other specialties. Emory Saint Joseph's Hospital is involved with conducting 320 clinical trials across 466 conditions. There are 58 research doctors associated with this hospital, such as Ticiana A. Leal, Conor Steuer, Olatunji Alese, and Mehmet Bilen, MD.
Where is Emory Saint Joseph's Hospital located?
**Emory Saint Joseph's Hospital** - **Address:** 5665 Peachtree Dunwoody Road, Atlanta, GA 30342. - **Directions:** From I-85N, take exit 87 for GA 400. Follow signs to Glenridge Connector, turn right onto Glenridge Road, and then left onto Peachtree Dunwoody Road.
Who should I call to ask about financial aid or insurance network?
**Emory Saint Joseph's Hospital Financial Assistance Information:** - For assistance with insurance and billing matters, contact the Financial Counselor to review your insurance coverage, discuss out-of-pocket obligations, and explore financial coverage options. Call the Patient Financial Services Department at Emory Healthcare at (404) 778-7318 for information on financial assistance programs, eligibility, and application process. - For specific billing and collection policies, contact the Patient Financial Services Department at (973) 754-2150 or request policies by mail at St. Joseph’s Health, Patient Financial Services, 35 Getty Avenue, 400 Hospital Plaza, Paterson, New Jersey 07503. - Emory Healthcare's Financial Assistance Policy, Plain Language Summary, and Financial Assistance Application Form are available for viewing and printing on their website.
What insurance does Emory Saint Joseph's Hospital accept?
Emory Saint Joseph's Hospital accepts a wide range of insurance plans, including but not limited to Medicaid (New York State), Medicare, Aetna, BlueCross BlueShield Association Blue Card Program, and Cigna. Coverage extends to plans through MVP Health Care and/or MultiPlan, Inc., Coventry Health Care Workers Compensation, EmblemHealth Plan, Inc., and Excellus BlueCross BlueShield. Additional insurers include Fidelis Care, First Health Network, Humana (Medicare plans only), Indian Health Service, and United Healthcare, among others.
What awards or recognition has Emory Saint Joseph's Hospital received?
Emory Saint Joseph's Hospital in Atlanta, Georgia, stands out for its nursing excellence, being the first community hospital globally to achieve seven consecutive Magnet designations from the American Nurses Credentialing Center's Magnet Recognition Program®. This honor signifies the highest national recognition for professional nursing practice, highlighting nursing professionalism, teamwork, and superior patient care. The hospital is also commended for excellence in eight areas, including high percentages of registered nurses with advanced degrees, surpassing benchmarks in patient experience and safety, and exceptional health promotion in rural Georgia hospitals.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.